Timmons O D, Havens P L, Fackler J C
University of Utah School of Medicine, Salt Lake City, USA.
Chest. 1995 Sep;108(3):789-97. doi: 10.1378/chest.108.3.789.
To estimate mortality risk in pediatric patients with acute hypoxemic respiratory failure (AHRF).
Retrospective chart review.
Forty-one pediatric ICUs.
Four hundred seventy children with AHRF. We defined AHRF as mechanical ventilation with positive end-expiratory pressure > or = 6 cm H2O and fraction of inspired oxygen greater than or equal to 0.5 for 12 or more hours.
Physiologic and treatment variables were recorded every 12 h for 14 days. Cases were randomly assigned to score development and score validation subsets. Variables were assessed for their association with mortality in the development subset by logistic regression analysis. The analysis generated a series of logistic equations, which we called the Pediatric Respiratory Failure (PeRF) score, to estimate mortality risk at 12-h intervals over the first 7 days of treatment for AHRF. The predictive ability of the score was assessed in the validation subset by receiver operating characteristic curve area and goodness-of-fit chi 2.
Mortality of the collected cases was 43%. The PeRF score included age, operative status, Pediatric Risk of Mortality score, fraction of inspired oxygen, respiratory rate, peak inspiratory pressure, positive end-expiratory pressure, PaO2, and PaCO2. Area under the receiver operating characteristic curve was 0.769 at entry and increased to greater than 0.8 after 36 h. When the score was applied to the validation subset of patients, goodness-of-fit chi 2 showed no significant difference between estimated and actual mortality between 0 and 96 h.
The PeRF Score accurately estimated mortality risk in this retrospectively sampled group of high-risk pediatric patients with AHRF. This score may be useful in studies of newer therapies for pediatric AHRF, though prospective validation is necessary before it could be used to make clinical decisions.
评估急性低氧性呼吸衰竭(AHRF)患儿的死亡风险。
回顾性病历审查。
41个儿科重症监护病房。
470例AHRF患儿。我们将AHRF定义为呼气末正压≥6 cm H2O且吸入氧分数≥0.5进行机械通气12小时或更长时间。
在14天内每12小时记录生理和治疗变量。病例被随机分配到评分开发和评分验证亚组。通过逻辑回归分析评估变量与开发亚组中死亡率的关联。该分析生成了一系列逻辑方程,我们称之为儿科呼吸衰竭(PeRF)评分,以估计AHRF治疗前7天每隔12小时的死亡风险。通过受试者工作特征曲线面积和拟合优度卡方检验在验证亚组中评估该评分的预测能力。
收集病例的死亡率为43%。PeRF评分包括年龄、手术状态、儿科死亡风险评分、吸入氧分数、呼吸频率、吸气峰压、呼气末正压、动脉血氧分压(PaO2)和动脉血二氧化碳分压(PaCO2)。受试者工作特征曲线下面积在入院时为0.769,36小时后增加到大于0.8。当将该评分应用于患者验证亚组时,拟合优度卡方检验显示在0至96小时之间估计死亡率与实际死亡率之间无显著差异。
PeRF评分准确估计了该组回顾性抽样的高危AHRF儿科患者的死亡风险。该评分可能有助于儿科AHRF新疗法的研究,但在用于临床决策之前需要进行前瞻性验证。